Londoño KJ, Caicedo GJ, Naranjo LE, Rivera PA

Language: Spanish
References: 14
Page: 1-10
PDF size: 386.39 Kb.

ABSTRACT

Introduction: Diabetes is considered a public health concern worldwide, and its management requires a pharmacological and lifestyle approach. Patient adherence to treatment turns out to be a determining factor to guarantee the success of the therapy and includes aspects related to medication, attendance at medical appointments, diet, and physical exercise.
Objective: To describe patient adherence to treatment within the diabetes program of an institution that provides healthcare services in Jamundí (Valle) Municipality, Colombia.
Methods: An observational cross-sectional study was carried out, in which a survey was applied including 25 questions related to sociodemographic characteristics, adherence to treatment, together with the application of the Morisky-Green test. Adherence was assessed in 57 diabetic patients belonging to the promotion and prevention program of an institution that provides healthcare services in Jamundí (Valle) Municipality.
Results: Low patient adherence (38.6%) to pharmacological treatment was found. Additionally, 61.4% of the patients were observed to have a healthy diet, while only 28.1% carried out frequent physical activity. There was evidence that 10.5% of the patients live in rural areas, and that most of the non-adherent ones turned out to have very low economic income, which could represent a difficulty for transportation and access to healthcare services. The study revealed great lack of knowledge about the disease by the patients, an aspect that could be crucial for adherence to treatment.
Conclusion: Low adherence of diabetic patients to treatment can cause therapeutic failure; its main causes are associated with economic factors, difficulty in accessing healthcare services, unhealthy lifestyles, and ignorance about their disease.

REFERENCES

1. Chetan MR, Thrower SL, Narendran P. What is type 1 diabetes? Medicine. 2019;47(1):5-9. DOI: https://doi.org/10.1016/j.mpmed.2018.10.006

2. Thrasher J. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies. Am J Med. 2017;130(6S):S4-S. DOI: 10.1016/j.amjmed.2017.04.004

3. Organización Mundial de la Salud. Informe mundial sobre la diabetes. Ginebra: OMS; 2016. [acceso 20/09/2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/254649/9789243565255- spa.pdf?sequence=1

4. OMS. Diabetes country profiles 2016. Ginebra: OMS 2016. [acceso 20/09/2019]. Disponible en: https://www.who.int/diabetes/country-profiles/col_en.pdf?ua=1

5. En el Valle del Cauca hay 105.000 personas con diabetes. El País. 13 de noviembre 2015 [acceso 12/09/2019]. Disponible en: https://www.elpais.com.co/cali/en-el-valle-del-caucahay- 105-000-personas-con-diabetes.html

6. Ritter J, Flower R, Henderson G, Loke Y, MacEwan D, Rang H. Rang & Dale’s Pharmacology. 9th Ed. London: Elsevier; 2019;p. 408-421.

7. Martín Alfonso L. Acerca del concepto de adherencia terapéutica. Rev Cub Sal Públ. 2004;30(4).

8. López-Romero LA, Romero-Guevara SL, Parra DI, Rojas-Sánchez LZ. Adherencia al tratamiento: concepto y medición. Hacia promoc Salud. 2016;21(1):117–37. Disponible en: http://www.scielo.org.co/pdf/hpsal/v21n1/v21n1a10.pdf

9. Mestre J, Vacca C, Angulo N, Orozco JG, Holguín E, Valcárcel R, Jimenez F, López JJ. Boletín de Farmacovigilancia-Fallo Terapéutico. Boletín 11. Año 3, Diciembre - Febrero 2005. [acceso 12/10/2019]. Disponible en: https://www.invima.gov.co/documents/20143/453029/4BOLETIN_11.pdf/aed23e95-3899- 5ce7-bfd1-e359793af5cb

10. Lauritsen JM, Bruus M. EpiData (version 4.0). A comprehensive tool for validated entry and documentation of data. Odense, Denmark : The EpiData Association; 2003-2005.

11. Rodríguez Chamorro MÁ, García-Jiménez E, Amariles P, Rodríguez Chamorro A, José Faus M. Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Atención Primaria. 2008;40(8):413-8.

12. Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes. 4a ed. Chicester, United Kingdom: Willey-Blackwell; 2011.

13. Ahmad SI. Diabetes: an old disease, a new insight. New York:Springer; 2013.

14. Egan AM, Dinneen SF. What is diabetes? Medicine. 2019;47(1):1-4. DOI: 10.1016/j.mpmed.2018.10.002.